posted
Press Release Source: XTend Medical Corporation
XTend Medical (XMDC) Signs Exclusive Distribution Agreement With Diabetes Detection, Inc., a Silicon Valley Company Friday September 28, 12:12 pm ET
XTend Medical to Be First to Market Global Diabetes Technology to Millions of Physicians
SUN VALLEY, CA--(MARKET WIRE)--Sep 28, 2007 -- XTend Medical Corporation (Other OTC:XMDC.PK - News) announced the company has signed an exclusive distribution agreement with Diabetes Detection, Inc. of Palo Alto, CA, manufacturer of medical testing devices. ADVERTISEMENT
Under the terms of the agreement, XTend will sell and distribute all medical device products developed by DDI for use in the early detection of diabetic neuropathy. Neuropathy detection is used to determine the extent to which diabetic patients lose feeling in their outer extremities. DDI's current medical testing device was developed in a pager unit wherein physicians have a mobile medical device that can check the vibration threshold of the patient, thereby determining their neuropathic loss. This can help the physician in determining the proper course of treatment to minimize any further damage to the patient's extremities and lower patient costs significantly.
"We're extremely pleased to finalize this agreement with DDI. Our company now has an additional medical device to market and sell to major healthcare companies so they can diagnose neuropathy levels in patients and assist in preventing further damage to the patient, while saving the managed care companies additional costs of patient care. With the global market of diabetic neuropathy increasing, the potential sales of this unit alone in the U.S. could well exceed $150 million over the next 3-4 years," stated Mr. Paul D. Lisenby, Chairman and CEO of XTend Medical.
This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
Contact: Company Contact: FutureTechIR for BioPharmetics Investor Relations (817) 812-2105
-------------------------------------------------------------------------------- Source: XTend Medical Corporation
Posts: 3056 | Registered: Feb 2005
| IP: Logged |
posted
XMDC-XTend Medical Corporation 10771 Sherman Way Sun Valley, CA 91352 P:(818) 255-2476 F:(818) 255-2479
General Inquiries info*xtendmedical.com
Managed Care Sales Pharmacy mcsales*xtendmedical.com pharmacy*xtendmedical.com
Investor Relations FutureTech IR (727) 417-9338 info*futuretechcapital.com
9/26/2007 SMMW Summus Works Inc. Common Stock XMDC XTend Medical Corporation Common Stock 1-8,334 R/S
(((The old management of SMMW sold out to a very legit ceo-imo--the new company has around 65 million out with around 8 million float--there has been some great news recently--And I EXPECT HUGE NEWS WITHIN 2 WEEKS, now at a PPS of .16--looking for dollars here imho.))))
posted
I know what the term means now... What is the benefit of a low floater? Because according to the website it becomes more volatile, which means it could change drastically up or down...
also becomes a target for groups who frontload, then hit the message boards pumping it; if they get a run going, they bail while telling folks "don't sell till a dollar" etc...
posted
XTend Medical (XDMC) Closes on 25% Acquisition of Medical Cost Management, Inc. (MCM) Thursday October 11, 9:30 am ET MCM to Help Secure Several Large Managed Health Care Contracts
SUN VALLEY, Calif., Oct. 11 /PRNewswire-FirstCall/ -- XTend Medical Corporation (Pink Sheets: XMDC - News) announced the company has finalized its due diligence and closed the letter of intent on Medical Cost Management, Inc and has acquired a twenty-five percent stake in the company. ADVERTISEMENT
"After completing our extensive due diligence on Medical Cost Management, Inc, we're proud to announce we've acquired a twenty-five percent stake in the company. We felt that it was important to secure a portion of MCM in order for XTend to have a dedicated and focused group of sales and marketing professionals as we work on gaining contracts with managed care companies which happens to be MCM's expertise in the healthcare field. We've also negotiated a first right of refusal to purchase the remaining 75% of the company over the next 2 years through a combination of cash and/or cash and stock," stated Mr. Paul D. Lisenby, Chairman and CEO of XTend Medical Corporation. Mr. Lisenby adds, "This acquisition was done through the issuance of 2,500,000 shares of common stock that came from the original issuance of founder shares in XTend Medical. This will have no effect on the current outstanding shares within the company. XTend will continue to seek out additional acquisition and alliance opportunities that will bring considerable value to the company in order for us to grow and prosper in the healthcare arena."
Medical Cost Management issued the following statement:
"Now that we've closed this deal with XTend, our company will have a much stronger position in securing contracts with our managed care clients. The support we will receive from XTend will assist us in our current negotiations with the managed care companies we currently are in negotiations with. We're excited to be a shareholder in XTend and will work closely with Mr. Lisenby to reach his projections for 2008 and beyond," stated Mr. Jose Santoro, CEO of MCM.
About MCM: Medical Cost Management currently works with several large Managed Health Care companies in the U.S. as well as other regional and local health care insurers throughout the U.S., Puerto Rico, and Canada.
About XTend Medical: XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients.
Safe Harbor
This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
Contact: Company Contact: FutureTechIR for XTend Medical Corporation Investor Relations (817) 812-2105
Posts: 3056 | Registered: Feb 2005
| IP: Logged |
posted
WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
NEW YORK, Oct 16, 2007 /PRNewswire via COMTEX/ -- On October 10, Paul D. Lisenby, CEO of XTend Medical Corporation (Pink Sheets: XMDC) updated the investment community in an all-new interview with www.wallst.net. Topics covered in the interview include an overview of the company and its growth strategy, recent press releases, market opportunity, and upcoming milestones for which investors should watch. To hear the interview in its entirety, visit http://www.wallst.net and click on "Interviews." The interview can be accessed either by locating the company's ticker symbol under the appropriate exchange at the top of the "Interviews" section of the site or by entering the company's ticker symbol in the Search Archive window.
About XTend Medical:
XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients.
About WallSt.net:
www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Web site is a leading provider of timely business news, executive interviews, multimedia content and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a financial social network for investors, and Financial Filings Corp., a provider of compliance solutions to publicly traded companies. Additionally, WallStreet Direct, Inc. owns and operates WallStRadio, a business and finance podcast Web site. Financial Filings Corp. has received one million two hundred fifty thousand restricted shares of XMDC from XTend Medical Corporation for media and advertising services. For a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp.
posted
(XDMC) Adds New Bluetooth(R) Telemedicine Products From A&D Medical Thursday October 18, 5:00 am ET Bluetooth(R) Wireless Blood Pressure Cuff and Weight Scale Added to Our Telemedicine Product Line
SUN VALLEY, Calif., Oct. 18 /PRNewswire-FirstCall/ -- XTend Medical Corporation (Pink Sheets: XMDC - News) announced the company has added two new Bluetooth® enabled telemedicine products to their line of disease management solutions for sales to managed care, hospitals, long term care facilities, and physician groups. ADVERTISEMENT
"The addition of A & D's Bluetooth® enabled Blood Pressure Cuff and Weight Scale will give us the opportunity to package our offerings to the various healthcare organizations in order to effectively monitor their patients with the most up to date technology in the healthcare arena. As we target the larger managed health care companies, this technology allows us to not only target diabetic patients, our main focus, but also gives us the ability to present to managed care companies a cutting-edge solution for chronic conditions in heart and kidney patients. This increases our opportunity to generate significant sales and imbeds us further with gaining additional long term contracts. XTend Medical, through R&D expenditures and exclusive agreements, continues to ensure our position as a leading provider of telemedicine products and services for years to come," stated Mr. Paul D. Lisenby, Chairman and CEO of XTend Medical.
About A & D:
A&D Medical is a division of A&D, an ISO 9002-registered company with operations in Asia, Europe, Australia, Russia, and North and South America. Since 1977, A&D Medical has manufactured and distributed a full line of advanced electronic blood pressure monitoring equipment and health care products for home and professional use. The company has established itself as a leader in home health monitoring technology through the development and introduction of a variety of unique products. A&D's LifeSource® blood pressure monitor line has garnered numerous industry awards. Recent product introductions include: the LifeSource® digital thermometers, personal scales, stethoscopes, and Ambulatory Blood Pressure Monitors.
XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients.
Safe Harbor: This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
Company Contact: FutureTechIR for XTend Medical Corporation
Investor Relations (817) 812-2105
-------------------------------------------------------------------------------- Source: XTend Medical Corporation
Posts: 3056 | Registered: Feb 2005
| IP: Logged |
XTend Medical CEO Discusses Company's Business Model
2007-10-24 06:31 ET - News Release
SUN VALLEY, Calif., Oct. 24, 2007 (PRIME NEWSWIRE) -- XTend Medical Corporation (Pink Sheets:XMDC) announced the company has launched a new corporate website. The new website is located at www.xtendmedical.com
In other news, CEO, Paul D. Lisenby issued the following statement regarding the company's business model and future for the company.
"We've worked very hard over the last month in structuring the company after our reverse merger with Summus Networks for success in the healthcare industry. The company has signed several strategic alliances and purchased a 25% interest in Medical Cost Management. By accomplishing this, we have positioned ourselves for our initial penetration into the healthcare industry and we're very near closing several contracts we've been working on for the past several months. We'd certainly like to speed up the process in closing these contracts, but when dealing with large healthcare organizations this does take time.
"The healthcare industry will continue to grow and XTend Medical is in a prime position to capitalize on these opportunities. Our initial focus will be on delivering products in the diabetic sector. This will allow us to gain monthly revenues that will have a 30-40% profit margin and help us reach our initial sales goals previously released. In addition, we will continue to look for acquisitions and alliances that will bring immediate revenue opportunities to the company. We're confident the company is poised to be a force within the industry. The strengths of the company are our targeted growing sector with cutting-edge technologies, our strong relationships with healthcare companies, and our programs and products designed to raise patient care while lowering costs for the managed care companies.
"I would also like to point out that all of the shares issued to the executives of the company, after the reverse merger with Summus, and the shares used to acquire Medical Cost Management are restricted under Rule 144. No insiders can sell any shares for at least a year. Our total commitment is to grow this company and bring value to all shareholders."
About XTend Medical
XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. www.xtendmedical.com
Safe Harbor
This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
CONTACT: FutureTechIR for XTend Medical Corporation Investor Relations (817) 812-2105
Posts: 3056 | Registered: Feb 2005
| IP: Logged |
posted
XTend Medical (XDMC) Signs Letter of Intent to Acquire Castle Hill Retirement Village and Assisted Living Facility Facility Comes With $5M in Yearly Revenue & $30M in Book Value SUN VALLEY, Calif., Oct. 29 /PRNewswire-FirstCall/ -- XTend Medical Corporation (Pink Sheets: XMDC) announced the company has signed a Letter of Intent to purchase the 150 Unit Castle Hill Retirement Village and Assisted Living Facility located in Thousand Oak, Ca, in primarily a cash transaction.
Pending the completion of our due diligence and obtaining a long term institutional funding package, the company expects to close this acquisition within 30 days.
'We look at this transaction to be a great opportunity for the company to execute and further its business plan through acquiring patients for our healthcare products. The assisted living facility (Castle Hill) and its property are valued at $30 million dollars and it currently brings in $5 million in yearly revenue. Our plans are to secure a long term institutional financing to not only acquire the property and its business but also to build out a 90 room dementia center that will add another $12 million in yearly revenue. The plans for the dementia center are already complete and the build out should take approximately 10-12 months. This will also allow XTend to institute a pharmacy center within the property and to market and sell our healthcare products to the current and future patients that reside at the facility.' stated Mr. Paul D. Lisenby, CEO of XTend Medical. Mr. Lisenby adds, 'With the success of this type of acquisition, we will continue acquiring Assisted Living Facilities all throughout the United States to continue our exponential organic growth and net tangible asset base. This acquisition also allows us to attain preferable position when applying for listing to a larger exchange such as AMEX or NASDAQ in 2008.'
To find out more about Castle Hill, please visit their website at www.castlehill.com
About XTend Medical
XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. For more information please visit us at http://www.xtendmedical.com.
Safe Harbor
This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
SOURCE XTend Medical Corporation
Source: PR Newswire (October 29, 2007 - 6:30 AM EDT)
posted
XTend Medical (XMDC) Completes Due Diligence on Castle Hill Acquisition Thursday November 1, 6:30 am ET
Acquisition Will Be Operated as a Wholly Owned Subsidiary of XTend Medical
SUN VALLEY, CA--(MARKET WIRE)--Nov 1, 2007 -- XTend Medical Corporation (Other OTC:XMDC.PK - News) announced the company has completed their due diligence on the Castle Hill Retirement Village and Assisted Living Facility. In addition, the company has submitted the necessary paperwork to the funding institution for the process of funding the acquisition.
"We've worked very diligently over the past four days to complete the necessary loan package sent over by the lending institution with the information required so they can begin the approval process. While we are confident the business model, revenue projections and profit forecast are sufficient in order to gain the funding, we simply now must wait for the approval process to take place. Our personal and business relationship with the lender will also play a major role in securing the funding," stated Mr. Paul D. Lisenby, CEO of XTend Medical. Mr. Lisenby further states, "As the Castle Hill facility will be run as a wholly owned subsidiary of XTend, the business operation will continue as it has in the past. All licenses, personnel, and operational aspects of Castle Hill will remain and no other changes will need to take place for the business to seamlessly become part of XTend Medical. We will work closely with the current management of Castle Hill in streamlining operations and begin the planning phase of the build-out of the dementia center as soon as the funding approval process is complete."
To find out more about Castle Hill, please visit their website at www.castlehill.com.
About XTend Medical: XTend Medical Corporation markets and sells healthcare and wellness products to hospitals, managed care companies, nursing homes, physician groups and individual patients. Through their alliances, XTend offers pharmacy services, diabetic supplies, and telemedicine products that increase patient care yet reduce costs associated with servicing those patients. www.xtendmedical.com.
Safe Harbor
This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.
Contact:
Company Contact: FutureTechIR for XTend Medical Corporation Investor Relations (817) 812-2105
Source: XTend Medical
Posts: 3056 | Registered: Feb 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
